315 related articles for article (PubMed ID: 17141345)
21. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
Gnegy ME; Hewlett GH; Pimputkar G
Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
[TBL] [Abstract][Full Text] [Related]
22. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice.
Scorza MC; Castañé A; Bortolozzi A; Artigas F
Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811
[TBL] [Abstract][Full Text] [Related]
23. N-Methyl-D-aspartate receptor antagonist MK-801 attenuates morphine tolerance and associated glial fibrillary acid protein up-regulation: a proteomic approach.
Wen ZH; Wu GJ; Hsu LC; Chen WF; Chen JY; Shui HA; Chou AK; Wong CS
Acta Anaesthesiol Scand; 2008 Apr; 52(4):499-508. PubMed ID: 18339156
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action.
Javitt DC; Duncan L; Balla A; Sershen H
Mol Psychiatry; 2005 Mar; 10(3):275-87. PubMed ID: 15278098
[TBL] [Abstract][Full Text] [Related]
25. Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated alzheimer's disease model.
Ahmed MM; Hoshino H; Chikuma T; Yamada M; Kato T
Neuroscience; 2004; 126(3):639-49. PubMed ID: 15183513
[TBL] [Abstract][Full Text] [Related]
26. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
27. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia.
Kesby JP; Burne TH; McGrath JJ; Eyles DW
Biol Psychiatry; 2006 Sep; 60(6):591-6. PubMed ID: 16697353
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
Duncan GE; Leipzig JN; Mailman RB; Lieberman JA
Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244
[TBL] [Abstract][Full Text] [Related]
29. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
Gattaz WF; Schummer B; Behrens S
J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
[TBL] [Abstract][Full Text] [Related]
30. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
[TBL] [Abstract][Full Text] [Related]
31. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
32. Dose-dependent effect of MK-801 on the levels of neuropeptides processing enzymes in rat brain regions.
Ahmed MM; Yamamoto M; Chikuma T; Rahman MK; Kato T
Neurosci Res; 2003 Oct; 47(2):177-89. PubMed ID: 14512142
[TBL] [Abstract][Full Text] [Related]
33. Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the D-serine levels in rat brain.
Hashimoto A; Yoshikawa M; Andoh H; Yano H; Matsumoto H; Kawaguchi M; Oka T; Kobayashi H
Eur J Pharmacol; 2007 Jan; 555(1):17-22. PubMed ID: 17109841
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.
Schmitt A; May B; Müller B; Jatzko A; Petroianu G; Braus DF; Henn FA
Pharmacopsychiatry; 2003 Nov; 36(6):292-6. PubMed ID: 14663653
[TBL] [Abstract][Full Text] [Related]
35. Blockade of MK-801-induced heat shock protein 72/73 in rat brain by antipsychotic and monoaminergic agents targeting D2, 5-HT1A, 5-HT2A and α1-adrenergic receptors.
Romón T; Planas AM; Adell A
CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):104-11. PubMed ID: 24040788
[TBL] [Abstract][Full Text] [Related]
36. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
[TBL] [Abstract][Full Text] [Related]
37. Characterization of MK-801-induced behavior as a putative rat model of psychosis.
Andiné P; Widermark N; Axelsson R; Nyberg G; Olofsson U; Mårtensson E; Sandberg M
J Pharmacol Exp Ther; 1999 Sep; 290(3):1393-408. PubMed ID: 10454519
[TBL] [Abstract][Full Text] [Related]
38. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
Hoffman KL; Basurto E
Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
[TBL] [Abstract][Full Text] [Related]
39. MK-801-induced dystonia in cebus monkeys.
Madsen M; Lublin H
Clin Neuropharmacol; 1998; 21(6):333-8. PubMed ID: 9844788
[TBL] [Abstract][Full Text] [Related]
40. NMDA glutamate receptor antagonist MK-801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine.
de Almeida V; Mendes ND; Zuccoli GS; Reis-de-Oliveira G; Almeida GM; Podolsky-Gondim GG; Neder L; Martins-de-Souza D; Sebollela A
J Neurochem; 2024 Mar; 168(3):238-250. PubMed ID: 38332572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
